The contractor shall provide preclinical development support for candidate products and drug development activities. The scope of work encompasses activities that range from initial product…
Active Awarded Last action
- Contract number
- 75N93021D00005
- Awardee
-
Starks Associates Inc. UEI DAY5FJMYL4L8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
Award facts
- Opportunity
-
- Preclinical Services for HIV Therapeutics Pre-Solicitation · 75N93019R00021 · Posted Oct 4, 2019
- Preclinical Services for HIV Therapeutics Solicitation · Posted Dec 5, 2019
- Last date to order 86% complete
- IDV ceiling
- $107,274,471.00
- Maximum order
- $107,274,471.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH) within the Department of Health and Human Services, has awarded a $107,274,471 multiple-award indefinite-delivery/indefinite-quantity (IDIQ) contract for Preclinical Services for HIV Therapeutics. The prime contractor, Starks Associates Inc., is a for-profit subchapter S corporation that will provide a range of preclinical development support services, from initial product discovery through clinical trial support. This includes synthesizing and acquiring compounds, conducting in vitro and in vivo testing, formulation development, and preclinical pharmacology and toxicology services. While primarily focused on HIV, the contract has flexibility to support other infectious disease priorities like hepatitis and tuberculosis. The contract does not carry any small business or other set-aside designations. Under this IDIQ, NIAID has issued several task orders to Starks Associates with individual values ranging from approximately $1.18 million to $1.26 million annually, performed on a cost-plus-fixed-fee basis at the company's facilities in Buffalo, New York.
Description
The contractor shall provide preclinical development support for candidate products and drug development activities. The scope of work encompasses activities that range from initial product discovery to those required to support clinical trials and/o
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93021D00005?
75N93021D00005 was awarded to Starks Associates Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on October 15, 2020.
How much is contract 75N93021D00005 worth?
75N93021D00005's own ceiling is $107,274,471. A single order can be worth up to $107,274,471.
Who can order from contract 75N93021D00005?
75N93021D00005 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93021D00005 part of a contract vehicle?
Yes. 75N93021D00005 is part of Preclinical Services for HIV Therapeutics.
Was contract 75N93021D00005 competed?
The extent of competition for 75N93021D00005 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV